Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
Antonio Pineda Guerrero, Research Trainee at INIT-UJI, shared a post on LinkedIn about a recent article by Daniel Ezzat published in European Heart Journal, adding:
“Elevated Lp(a) raises VTE risk but only in the right hormonal context
Prior studies found inconsistent results. The missing variable: Oestrogen.
In the European Heart Journal, data from 373,360 UK Biobank participants (13.6-year follow-up), Lp(a) at or above 125 nmol/L increased VTE risk in premenopausal women (aHR 1.32) and postmenopausal MHT users (aHR 1.48) but not in men or untreated postmenopausal women.
Same molecule. Opposite risk. Depending on hormonal milieu.
Should Lp(a) be part of the conversation before starting hormone therapy?”
Title: Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men
Authors: Daniel Ezzat, Diana M Lopez, Brian L Claggett, Linke Li, Niekbachsh Mohammadnia, Art Schuermans, Jan Hemeryck, Annie Chang, Samantha Murillo, Michelle L O’Donoghue, Behnood Bikdeli, Zhi Yu, Pradeep Natarajan, Aniruddh P Patel, Maria A Pabon, Michael C Honigberg
Read the Full Article on European Heart Journal

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis